Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis

<b>Rationale:</b> Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are both genetic diseases of mucociliary clearance resulting in progressive lung disease with onset in early life. PCD is often considered to be milder than CF in childhood, based on minimal evidence. Similar to CF, genotype-phenotype associations exist in PCD; pathogenic variants in <i>CCDC39</i> and <i>CCDC40</i>, causing inner dynein arm/microtubular defects (IDA/MTD), are associated with more severe disease. <b>Objectives:</b> To compare longitudinal outcomes in matched children with PCD and CF. We hypothesized that children with PCD with IDA/MTD defects would have lower lung function but better nutritional indices than matched children with CF with minimal function genotypes (i.e., those associated with pancreatic insufficiency). <b>Methods:</b> Children with PCD enrolled in a prospective, multicenter, observational study were matched with patients with CF from the Cystic Fibrosis Foundation Patient Registry by birth cohort, age, sex, race/ethnicity, and year of study visit. The association of disease group overall and by severity class (PCD-IDA/MTD vs. all other defects and CF-minimal vs. residual function) with longitudinal outcomes up to age 17 was evaluated with cubic spline mixed effects models. <b>Results:</b> Groups included 136 children with PCD (40 IDA/MTD, 96 other) and 476 with CF (446 minimal function, 30 residual function). Below age 14, the PCD group had similar or lower estimated mean forced expiratory volume in 1 second percent predicted compared with CF (e.g., at age 10, -5.4% predicted lower; 95% confidence interval [CI], -7.7, -3.1). Compared with the CF-minimal function (pancreatic insufficient) group, the PCD-IDA/MTD group had similar body mass index; estimated mean forced expiratory volume in 1 second percent predicted was significantly lower by age 10 (mean difference, -10.6%; 95% CI, -14.7, -6.4), increasing at age 14 (mean difference, -15.7%; 95% CI, -20.3, -11.2). The CF cohort had increased prevalence of <i>Pseudomonas aeruginosa</i> cultured on one or more occasions compared with children with PCD (67% vs. 27%; <i>P</i> < 0.001); there was no difference in the prevalence of <i>P. aeruginosa</i> between children with PCD-IDA/MTD and PCD-other. <b>Conclusions:</b> In childhood, average lung function abnormalities in PCD are not milder than CF, particularly for those with IDA/MTD ciliary defects. New guidelines and treatments to improve outcomes in PCD are urgently needed.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2024-10-09
DOI
https://doi.org/10.1513/annalsats.202311-1008oc
Citations
6
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
2.51
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis

Margaret W. Leigh, Sharon Dell, Maimoona A. Zariwala, Marshall Brown et al.
6 citations
Annals of the American Thoracic Society
Cystic Fibrosis Research Advances
2.51
article

Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis

Margaret W. Leigh, Sharon Dell, Maimoona A. Zariwala, Marshall Brown, Adam J. Shapiro, Rhonda D. Szczesniak, Kelli M. Sullivan, Michael R. Knowles, Stephanie D. Davis, Frankline Onchiri, Scott D. Sagel, BreAnna Kinghorn, Margaret Rosenfeld, Carlos Milla, Jessica E. Pittman, Erin Sullivan, Thomas Ferkol
article en
6 citations

Abstract

<b>Rationale:</b> Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are both genetic diseases of mucociliary clearance resulting in progressive lung disease with onset in early life. PCD is often considered to be milder than CF in childhood, based on minimal evidence. Similar to CF, genotype-phenotype associations exist in PCD; pathogenic variants in <i>CCDC39</i> and <i>CCDC40</i>, causing inner dynein arm/microtubular defects (IDA/MTD), are associated with more severe disease. <b>Objectives:</b> To compare longitudinal outcomes in matched children with PCD and CF. We hypothesized that children with PCD with IDA/MTD defects would have lower lung function but better nutritional indices than matched children with CF with minimal function genotypes (i.e., those associated with pancreatic insufficiency). <b>Methods:</b> Children with PCD enrolled in a prospective, multicenter, observational study were matched with patients with CF from the Cystic Fibrosis Foundation Patient Registry by birth cohort, age, sex, race/ethnicity, and year of study visit. The association of disease group overall and by severity class (PCD-IDA/MTD vs. all other defects and CF-minimal vs. residual function) with longitudinal outcomes up to age 17 was evaluated with cubic spline mixed effects models. <b>Results:</b> Groups included 136 children with PCD (40 IDA/MTD, 96 other) and 476 with CF (446 minimal function, 30 residual function). Below age 14, the PCD group had similar or lower estimated mean forced expiratory volume in 1 second percent predicted compared with CF (e.g., at age 10, -5.4% predicted lower; 95% confidence interval [CI], -7.7, -3.1). Compared with the CF-minimal function (pancreatic insufficient) group, the PCD-IDA/MTD group had similar body mass index; estimated mean forced expiratory volume in 1 second percent predicted was significantly lower by age 10 (mean difference, -10.6%; 95% CI, -14.7, -6.4), increasing at age 14 (mean difference, -15.7%; 95% CI, -20.3, -11.2). The CF cohort had increased prevalence of <i>Pseudomonas aeruginosa</i> cultured on one or more occasions compared with children with PCD (67% vs. 27%; <i>P</i> < 0.001); there was no difference in the prevalence of <i>P. aeruginosa</i> between children with PCD-IDA/MTD and PCD-other. <b>Conclusions:</b> In childhood, average lung function abnormalities in PCD are not milder than CF, particularly for those with IDA/MTD ciliary defects. New guidelines and treatments to improve outcomes in PCD are urgently needed.

Annals of the American Thoracic SocietyVol. 21(12)
University of North Carolina at Chapel Hill (US), University of British Columbia (CA), University of Washington (US), Washington University in St. Louis (US), McGill University Health Centre (CA), Children's Hospital Colorado (US), Lung Institute (US), University of Cincinnati (US), University of Cincinnati Medical Center (US), University of Colorado Denver (US), Stanford University (US)
Zero hunger
Openalex Percentile: Top 10%
Cystic Fibrosis Research Advances
2.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.